These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33142186)

  • 1. Impaired repolarization parameters may predict fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy (from the CILICIA Registry).
    Güner A; Kalçık M; Çelik M; Uzun F; Çizgici AY; Ağuş HZ; Aslan S; Güner EG; Ulutaş AE; Bayam E; Kalkan ME
    J Electrocardiol; 2020; 63():83-90. PubMed ID: 33142186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between myocardial bridging and fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy: the HCM-MB study.
    Güner A; Atmaca S; Balaban İ; Türkmen İ; Çeneli D; Türkvatan A; Öner E; Sürgit Ö; Güler A; Uzun F; Babür Güler G; Kahraman S; Pala S; Havan N; Yıldız M; Ertürk M
    Herz; 2023 Oct; 48(5):399-407. PubMed ID: 37081129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.
    Riza Demir A; Celik Ö; Sevinç S; Uygur B; Kahraman S; Yilmaz E; Cemek M; Onal Y; Erturk M
    Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12672. PubMed ID: 31152489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between impaired repolarization parameters and poor cardiovascular clinical outcomes in patients with potentially serious coronary artery anomalies.
    Kalkan ME; Güner A; Kalçik M; Turna Ö; Cansever AT; Uzun F; Akgün T; Aslan S; Güner EG; Çörekçioğlu B; Akman C; Ulutaş AE; Ertürk M
    Coron Artery Dis; 2022 Jan; 31(1):e27-e36. PubMed ID: 34010185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy.
    Akboğa MK; Gülcihan Balcı K; Yılmaz S; Aydın S; Yayla Ç; Ertem AG; Ünal S; Balcı MM; Balbay Y; Aras D; Topaloğlu S
    Anatol J Cardiol; 2017 Jul; 18(1):48-53. PubMed ID: 28315570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
    Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
    Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular Repolarization Dispersion is a Potential Risk for the Development of Life-Threatening Arrhythmia in Children with Hypertrophic Cardiomyopathy.
    Tashiro N; Muneuchi J; Ezaki H; Kobayashi M; Yamada H; Sugitani Y; Watanabe M
    Pediatr Cardiol; 2022 Oct; 43(7):1455-1461. PubMed ID: 35284943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Hypertrophic Cardiomyopathy, the Spatial Peaks QRS-T Angle Identifies Those With Sustained Ventricular Arrhythmias.
    Cortez D; Graw S; Mestroni L
    Clin Cardiol; 2016 Aug; 39(8):459-63. PubMed ID: 27175825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Quantification of Abnormal QRS Peaks From High-Resolution ECGs Predicts Late Ventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 5-Year Prospective Multicenter Study.
    Suszko AM; Chakraborty P; Viswanathan K; Barichello S; Sapp J; Talajic M; Laksman Z; Yee R; Woo A; Spears D; Adler A; Rakowski H; Chauhan VS
    J Am Heart Assoc; 2022 Dec; 11(23):e026025. PubMed ID: 36444865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT-interval abnormalities in hypertrophic cardiomyopathy.
    Dritsas A; Sbarouni E; Gilligan D; Nihoyannopoulos P; Oakley CM
    Clin Cardiol; 1992 Oct; 15(10):739-42. PubMed ID: 1395184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy.
    O'Mahony C; Lambiase PD; Rahman SM; Cardona M; Calcagnino M; Quarta G; Tsovolas K; Al-Shaikh S; McKenna W; Elliott P
    Europace; 2012 May; 14(5):724-33. PubMed ID: 22094454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy.
    Wen SN; Zhu HJ; Sun PY; Wu K; Liu N; Ruan YF; Bai R; Tang RB; Yu RH; Long DY; Sang CH; Jiang CX; Li X; Li SN; Hu R; Du X; Dong JZ; Ma CS
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2405-2413. PubMed ID: 31441155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Ventricular Repolarization in Sickle Cell Anemia Patients: The Role of QTc Interval, Tp-e Interval and Tp-e/QTc Ratio and Its Gender Implication.
    Ajibare AO; Olabode OP; Fagbemiro EY; Akinlade OM; Akintunde AA; Akinpelu OO; Olatunji LA; Soladoye AO; Opadijo OG
    Vasc Health Risk Manag; 2020; 16():525-533. PubMed ID: 33324066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can abnormal dispersion of ventricular repolarization be a predictor of mortality in arrhythmogenic right ventricular cardiomyopathy: The importance of Tp-e interval.
    Cekirdekci EI; Bugan B
    Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12619. PubMed ID: 30412321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of the QTc interval predicts appropriate implantable cardioverter-defibrillator therapies in hypertrophic cardiomyopathy.
    Gray B; Ingles J; Medi C; Semsarian C
    JACC Heart Fail; 2013 Apr; 1(2):149-55. PubMed ID: 24621839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy.
    Patel SI; Ackerman MJ; Shamoun FE; Geske JB; Ommen SR; Love WT; Cha SS; Bos JM; Lester SJ
    Acta Cardiol; 2019 Feb; 74(1):53-58. PubMed ID: 29513133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases.
    Benítez Ramos DB; Cabrera Ortega M; Castro Hevia J; Dorantes Sánchez M; Alemán Fernández AA; Castañeda Chirino O; Cruz Cardentey M; Martínez López F; Falcón Rodríguez R
    Pediatr Cardiol; 2017 Dec; 38(8):1663-1671. PubMed ID: 28871362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.